この専門家をプロジェクトに採用したいですか? 見積もりを依頼 無料で。
プロフィール詳細
Jack H.に依頼
United Kingdom
Health economist with extensive experience in systematic reviews, economic modelling and economic evaluations.
プロフィール概要
専門分野
サービス
職務経験
Health Economist (Associate, Senior Associate, Manager)
FIECON
12月 2017 - 6月 2021
Health Economist (Associate, Senior Associate, Manager)
Fiecon
12月 2017 - 6月 2021 ![]()
学歴
BS Mathematics
The University of Birmingham
9月 2014 - 7月 2017
Mathematics BSc
University of Birmingham
9月 2014 - 7月 2017 ![]()
認定資格
- 認定資格の詳細は未入力です。
出版物
JOURNAL ARTICLE
V. Laskier and E. Bertranou and J. Hansen-Maughan and J. Oddsdottir(2019). PREDICTOR OF A POSITIVE RECOMMENDATION IN NICE ONCOLOGY APPRAISALS . Value in Health. 22. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString S505. Elsevier {BV}
L. Walder and J. Hansen-Maughan and J. Oddsdottir and N. Scheffer-Apecechea(2019). THE UPTAKE AND IMPACT OF THE EQ-5D-5L VALUE SET IN NICE TECHNOLOGY APPRAISALS WITHIN ONCOLOGY . Value in Health. 22. Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString S502--S503. Elsevier {BV}
Holly Guy and Lydia Walder and Mark Fisher(2019). Cost-Effectiveness of Niraparib Versus Routine Surveillance, Olaparib and Rucaparib for the Maintenance Treatment of Patients with Ovarian Cancer in the United States . PharmacoEconomics. 37. (3). Microsoft.AspNetCore.Mvc.Localization.LocalizedHtmlString 391--405. Springer Science and Business Media {LLC}